Hospital De Messejana Dr. Carlos Alberto Studart Gomes

This study tests whether a newer drug, finerenone, is safer than an older drug, spironolactone, for people with heart failure, diabetes, and kidney disease who are at risk for high potassium levels. About 60 participants will receive either finerenone daily or spironolactone ever…